Mikkel Nørholm

Title: Mikkel Nørholm: Innovator in RNA Quantification

Introduction

Mikkel Nørholm is a distinguished inventor based in København V, Denmark. He has made significant contributions to the field of molecular biology, particularly in the quantification of ribonucleic acids. With a total of 2 patents, Nørholm's work has implications for understanding various human diseases, including cancer.

Latest Patents

Nørholm's latest patents focus on methods for the quantification of microRNAs and small interfering RNAs (siRNAs). These inventions relate to ribonucleic acids, probes, and methods for detection, quantification, and monitoring the expression of mature microRNAs and siRNAs. Furthermore, his inventions encompass methods for monitoring the expression of other non-coding RNAs, mRNA splice variants, and detecting and quantifying RNA editing, allelic variants of single transcripts, mutations, deletions, or duplications of particular exons in transcripts. These advancements are crucial for identifying alterations associated with human diseases such as cancer. Additionally, his patents include methods for the detection and quantification of deoxyribonucleic acids.

Career Highlights

Mikkel Nørholm is currently associated with Exiqon A/S, a company known for its innovative solutions in the field of molecular diagnostics. His work at Exiqon has allowed him to push the boundaries of RNA research and contribute to advancements in medical science.

Collaborations

Nørholm has collaborated with notable colleagues, including Nana Jacobsen and Lars Kongsbak. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in molecular biology.

Conclusion

Mikkel Nørholm's contributions to the field of RNA quantification are invaluable. His patents and work at Exiqon A/S highlight his commitment to advancing scientific knowledge and improving diagnostic methods. His innovative spirit continues to inspire future research in molecular biology.